HK1030552B - 药物组合物 - Google Patents

药物组合物 Download PDF

Info

Publication number
HK1030552B
HK1030552B HK01101617.0A HK01101617A HK1030552B HK 1030552 B HK1030552 B HK 1030552B HK 01101617 A HK01101617 A HK 01101617A HK 1030552 B HK1030552 B HK 1030552B
Authority
HK
Hong Kong
Prior art keywords
amino
purin
cyclopentene
cis
methanol
Prior art date
Application number
HK01101617.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1030552A1 (zh
Inventor
Thoennes Brooks Nikki
Original Assignee
葛兰素集团有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9802472.2A external-priority patent/GB9802472D0/en
Application filed by 葛兰素集团有限公司 filed Critical 葛兰素集团有限公司
Publication of HK1030552A1 publication Critical patent/HK1030552A1/zh
Publication of HK1030552B publication Critical patent/HK1030552B/zh

Links

HK01101617.0A 1998-02-06 1999-02-04 药物组合物 HK1030552B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9802472.2 1998-02-06
GBGB9802472.2A GB9802472D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compositions
PCT/EP1999/000663 WO1999039691A2 (en) 1998-02-06 1999-02-04 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
HK1030552A1 HK1030552A1 (zh) 2001-05-11
HK1030552B true HK1030552B (zh) 2003-08-15

Family

ID=

Similar Documents

Publication Publication Date Title
US20050069585A1 (en) Diphenhydramine tannate liquid and semi-solid compositions and methods of use
KR20020031331A (ko) 미토콘드리아 관련 질환의 치료방법
FR2727015A1 (fr) Compositions pharmaceutiques liquides a base d'ondansetron
CN109893502A (zh) 一种枸橼酸托法替布组合物及其制备方法
EP1051156B1 (en) Pharmaceutical compositions
PL189527B1 (pl) Półsiarczan (1S,4R)-cis-4-[2-amino-6-(cyklopropyloamino)-9H-puryn-9-ylo]-2-cyklopenteno-1-metanolu,jego zastosowanie i sposób wytwarzania, preparat farmaceutyczny, sól kwasu glutarowego, monosiarczan, benzoesan lub salicylan (1S,4R)-cis-4-[2-amino-6-(cyklopropyloamino)-9H-puryn-9-ylo]-2-cyklopenteno-1-metanolu
WO2014041551A1 (en) Formulation comprising imatinib as oral solution
HK1030552B (zh) 药物组合物
WO1998052570A1 (en) Antiviral combinations containing the carbocyclic nucleoside 1592u89
MXPA00007620A (en) Pharmaceutical compositions
US20030104017A1 (en) Epinastine formulation for oral administration
US11878994B1 (en) Compositions for treatment of inflammation
AU8017298A (en) Antiviral combinations containing the carbocyclic nucleoside 1592u89
HK40048071A (zh) 异喹啉磺酰胺的新形态
CA2425031A1 (en) Pharmaceutical compositions
HK1024236B (zh) 碳环核苷半硫酸盐和它在治疗病毒性感染中的应用